1. Home
  2. KW vs SPRY Comparison

KW vs SPRY Comparison

Compare KW & SPRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KW
  • SPRY
  • Stock Information
  • Founded
  • KW 1977
  • SPRY 2015
  • Country
  • KW United States
  • SPRY United States
  • Employees
  • KW N/A
  • SPRY N/A
  • Industry
  • KW Real Estate
  • SPRY Biotechnology: Pharmaceutical Preparations
  • Sector
  • KW Finance
  • SPRY Health Care
  • Exchange
  • KW Nasdaq
  • SPRY Nasdaq
  • Market Cap
  • KW 1.4B
  • SPRY 1.2B
  • IPO Year
  • KW 1992
  • SPRY N/A
  • Fundamental
  • Price
  • KW $6.51
  • SPRY $13.77
  • Analyst Decision
  • KW Hold
  • SPRY Strong Buy
  • Analyst Count
  • KW 1
  • SPRY 4
  • Target Price
  • KW $13.00
  • SPRY $28.75
  • AVG Volume (30 Days)
  • KW 932.0K
  • SPRY 1.7M
  • Earning Date
  • KW 05-07-2025
  • SPRY 05-08-2025
  • Dividend Yield
  • KW 7.54%
  • SPRY N/A
  • EPS Growth
  • KW N/A
  • SPRY N/A
  • EPS
  • KW N/A
  • SPRY 0.08
  • Revenue
  • KW $511,600,000.00
  • SPRY $89,149,000.00
  • Revenue This Year
  • KW $30.34
  • SPRY $1.49
  • Revenue Next Year
  • KW $4.80
  • SPRY $141.68
  • P/E Ratio
  • KW N/A
  • SPRY $172.06
  • Revenue Growth
  • KW N/A
  • SPRY 297063.34
  • 52 Week Low
  • KW $6.28
  • SPRY $7.55
  • 52 Week High
  • KW $11.88
  • SPRY $18.51
  • Technical
  • Relative Strength Index (RSI)
  • KW 31.73
  • SPRY 51.87
  • Support Level
  • KW $6.28
  • SPRY $13.77
  • Resistance Level
  • KW $6.80
  • SPRY $15.44
  • Average True Range (ATR)
  • KW 0.42
  • SPRY 1.01
  • MACD
  • KW -0.01
  • SPRY -0.02
  • Stochastic Oscillator
  • KW 22.62
  • SPRY 54.12

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

About SPRY ARS Pharmaceuticals Inc.

ARS Pharmaceuticals Inc is a biopharmaceutical company focused on the development of novel, potentially first-in-class product candidate, neffy for the emergency treatment of Type I allergic reactions, including anaphylaxis. neffy is a proprietary composition of epinephrine with an absorption enhancer called Intravail, which allows neffy to provide injection-like absorption of epinephrine at a low dose, in a small, easy-to-carry, easy-to-use, rapidly administered and reliable nasal spray.

Share on Social Networks: